Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 2/20 | 0.58 |
| ▸ | MAOB | P27338 | 11/20 | 0.53 |
| ▸ | MLNR | O43193 | 1/20 | 0.52 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.51 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.50 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.50 |
| ▸ | SCN3A | Q9NY46 | 2/20 | 0.48 |
| ▸ | HTR6 | P50406 | 1/20 | 0.48 |
| ▸ | MAOA | P21397 | 4/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL2193649 | 0.99 | F10 (0.57) | F10MAOBMLNRNR4A2KCNH2 | |
| SCHEMBL13806368 | 0.88 | F10 (0.45) | F10MLNR | |
| SCHEMBL12420561 | 0.82 | HTR6 (0.52) | MAOBNR4A2KCNH2PARP10SCN3A | |
| Hydrochloric Acid SCHEMBL2192668 | 0.81 | MAOB (0.51) | MAOBNR4A2KCNH2PARP10SCN3A | |
| SCHEMBL12420557 | 0.81 | NR4A2 (0.63) | F10MAOBNR4A2KCNH2PARP10 | |
| SCHEMBL12420571 | 0.81 | MAOB (0.59) | MAOBNR4A2KCNH2PARP10SCN3A | |
| Hydrochloric Acid SCHEMBL2198187 | 0.80 | NR4A2 (0.62) | F10MAOBNR4A2KCNH2PARP10 | |
| Hydrochloric Acid SCHEMBL2195214 | 0.80 | MAOB (0.58) | MAOBNR4A2KCNH2PARP10SCN3A | |
| SCHEMBL12509340 | 0.77 | F10 (0.57) | F10 | |
| SCHEMBL18894362 | 0.76 | F10 (0.62) | F10MAOBNR4A2KCNH2HTR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110172230-A1 | UREA COMPOUND OR SALT THEREOF | ASTELLAS PHARMA INC. (JP) | 2011-07-14 | — | — | US | disclosed |
| US-20110172230-A1 | UREA COMPOUND OR SALT THEREOF | ASTELLAS PHARMA INC. (JP) | 2011-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110172230-A1 | UREA COMPOUND OR SALT THEREOF | FAAH, FAAH2, UTS2R | F10 1851/4885MAOB 222/4885MLNR 2758/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.